Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
deals
4
×
biotech
clinical trials
life sciences
national blog main
boston blog main
boston top stories
fda
new york blog main
the medicines company
achaogen
adams street partners
alirocumab
alnylam pharmaceuticals
amgen
antibiotics
bayer
beta lactamase inhibitor
biomedical advanced research and development authority (barda)
biopharmaceutical
boston
business
cronos group
drug resistance
drugs
evolocumab
ginkgo bioworks
google
hatteras venture partners
health
hyperammonemia
inclisiran
investing
james collins
liver diseases
lyzz capital
macrolide pharmaceuticals
melinta therapeutics
meropenem
michael dudley
What
company
4
×
medicines
4
×
bacteria
biopharma
drug
new
year
abbott
abbvie
acquire
agreed
agreement
announced
backed
billion
biology
biotech
bioworks
brings
business
calico
called
cash
center
cholesterol
companies
compound
comprised
countries
deal
developer
disease
employes
engineered
exited
facility
fda
fighting
firm
formed
Language
unset
Current search:
deals
×
medicines
×
company
×
@xconomy.com
4 years ago
Novartis to Acquire MedCo and FDA-Ready Cholesterol Drug for $9.7B
@xconomy.com
4 years ago
Synlogic Lands $80M from Ginkgo to Ramp Up “Living Medicines” R&D
@xconomy.com
5 years ago
Qpex Biopharma Launches with $33M to Tackle Drug-Resistant Infections
@venturebeat.com
9 years ago
Google-backed Calico and Abbott Labs spinoff will set up $1.5B research center